Sökning: WFRF:(Daka Bledar) > (2009) > Low agreement betwe...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 05175naa a2200769 4500 | |
001 | oai:gup.ub.gu.se/107456 | |
003 | SwePub | |
008 | 240528s2009 | |||||||||||000 ||eng| | |
009 | oai:lup.lub.lu.se:4360cdeb-9111-4193-9511-096aab73e607 | |
009 | oai:DiVA.org:umu-35866 | |
024 | 7 | a https://gup.ub.gu.se/publication/1074562 URI |
024 | 7 | a https://doi.org/10.1080/089169309029117202 DOI |
024 | 7 | a https://lup.lub.lu.se/record/14898162 URI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-358662 URI |
040 | a (SwePub)gud (SwePub)lud (SwePub)umu | |
041 | a eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Daka, Bledar,d 1976u Umeå universitet,Allmänmedicin4 aut0 (Swepub:gu)xdakbl |
245 | 1 0 | a Low agreement between radio binding assays in analyzing glutamic acid decarboxylase (GAD65Ab) autoantibodies in patients classified with type 2 diabetes. |
264 | c 2009-09-09 | |
264 | 1 | b Informa UK Limited,c 2009 |
338 | a electronic2 rdacarrier | |
520 | a Autoantibodies against glutamic acid decarboxylase (GAD65Ab) are used in the classification of diabetes in adults. We assessed the concordance in GAD65 autoantibody levels within subjects between three different GAD65Ab radio binding assays (RBA). Plasma samples from 112 diabetes patients (median age 50 years) initially classified with type 2 diabetes was randomly selected from a local diabetes registry. Coded samples were analyzed with two RBA employing (35)S-labeled GAD65. The first used the pEx9 plasmid (pEx9 RBA), the second employed the pThGAD65 plasmid (pThGAD65 RBA) to label GAD65 by in vitro transcription translation. We also used a commercial kit employing plasmid pGAD17 labelled with (125)I (pGAD17 RBA). Subsequent analyses followed standard procedures. Two different cut-offs for GAD65Ab positivity were used in all three assays. We calculated the correlation, concordance, and agreement between the assays. The proportion of GAD65Ab positivity differed between assays when low cut-offs were used (pEx9 RBA 25%, pThGAD65 RBA 17.9%, and pGAD17 RBA 12.5%, respectively). When high cut-offs were applied, the concordance between the pEx9 RBA and the pThGAD65 RBA was 97.3 while their concordance to the pGAD17 RBA was lower (88.4 and 87.4, respectively). There was a low agreement between both pEx9 RBA and pGAD17 RBA (0.45, 95% CI 0.20-0.70) and between pThGAD65 RBA and pGAD17 RBA (0.43, 95% CI 0.18-0.68). We found discrepancies in determining the GAD65Ab positivity, which constitutes a problem when GAD65Ab are used clinically. Further methodological GAD65Ab assays studies are warranted. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Allmänmedicin0 (SwePub)302242 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex General Practice0 (SwePub)302242 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Reumatologi och inflammation0 (SwePub)302102 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Rheumatology and Autoimmunity0 (SwePub)302102 hsv//eng |
653 | a Adult | |
653 | a Autoantibodies | |
653 | a blood | |
653 | a Autoimmunity | |
653 | a Diabetes Mellitus | |
653 | a Type 2 | |
653 | a diagnosis | |
653 | a immunology | |
653 | a Glutamate Decarboxylase | |
653 | a genetics | |
653 | a immunology | |
653 | a Humans | |
653 | a Middle Aged | |
653 | a Plasmids | |
653 | a Radioligand Assay | |
653 | a methods | |
653 | a Reagent Kits | |
653 | a Diagnostic | |
653 | a Reproducibility of Results | |
653 | a autoimmunity | |
653 | a Type 1 diabetes | |
653 | a type 2 diabetes | |
653 | a immunological technique | |
653 | a Type 1 diabetes | |
700 | 1 | a Svensson, M.K,d 1965u Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine4 aut0 (Swepub:gu)xsmara |
700 | 1 | a Lernmark, Ke4 aut |
700 | 1 | a Mincheva-Nilsson, Lucia,d 1951-u Umeå universitet,Klinisk immunologi4 aut0 (Swepub:umu)lumi0001 |
700 | 1 | a Hallmans, Göranu Umeå universitet,Näringsforskning4 aut0 (Swepub:umu)goha0001 |
700 | 1 | a Rolandsson, Olovu Umeå universitet,Allmänmedicin4 aut0 (Swepub:umu)olro0005 |
700 | 1 | a Lernmark, Åkeu Lund University,Lunds universitet,Celiaki och diabetes,Forskargrupper vid Lunds universitet,Celiac Disease and Diabetes Unit,Lund University Research Groups4 aut0 (Swepub:lu)endo-ale |
710 | 2 | a Umeå universitetb Allmänmedicin4 org |
773 | 0 | t Autoimmunityd : Informa UK Limitedg 42:6, s. 507-14q 42:6<507-14x 1607-842Xx 0891-6934 |
856 | 4 | u https://gup.ub.gu.se/publication/107456x primaryx freey FULLTEXT |
856 | 4 | u http://dx.doi.org/10.1080/08916930902911720y FULLTEXT |
856 | 4 8 | u https://gup.ub.gu.se/publication/107456 |
856 | 4 8 | u https://doi.org/10.1080/08916930902911720 |
856 | 4 8 | u https://lup.lub.lu.se/record/1489816 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-35866 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.